The Iranian pharmaceutical market experiences cyclical crises and shortages. These shortages sometimes extend to simple cold pills and serum, but certain medications are perpetually in crisis, such as specialized drugs, insulin, or chemotherapy-related drugs. Meanwhile, the head of Iran's Food and Drug Organization claims that 99% of the country's medicines are domestically produced, yet the state of drug shortages indicates that production volumes have not met the country's healthcare needs. Due to market shortages and demand levels, smuggled imported drugs are bought and sold in the black market and online. A drug seller on Telegram tells Radio Farda: "Pharmacies have no insulin, only the Red Crescent. Farmaton cannot be found in pharmacies. However, there is a free market. The situation for cancer patients' medications is always critical. But all shortages can be found in the free market." The free or black market for drugs has now reached from Nasir Khusrow to Telegram. From self-sufficiency in production to a drug crisis, while government officials claim that pharmaceutical factories are operating at full capacity, the state of pharmacies does not confirm this. Seyyed Haidar Mohammadi, Deputy Minister of Health and head of the Food and Drug Organization, has claimed that a large portion of medications exists within the country. He stated: "Many cancer drugs are produced in domestic pharmaceutical companies with high quality. One percent of the country's drug needs are met through imports, which, however, account for 13% of the total monetary value of our drugs." Accordingly, Iran only needs 1% of drug imports, but the people's problems in obtaining and securing medications do not corroborate the claim of 99% domestic production. Citizens are wandering in front of a pharmacy in Tehran to secure medication. The newspaper Etemad has reported on drug shortages in various cities and public hospitals. Serum in a public hospital in Isfahan has been rationed due to shortages. The lack of narcotic drugs, declining quality of medications, and the absence of surgical blades and gloves are other points mentioned in this report. The Iranian government owes 60 trillion tomans to pharmaceutical companies. This list can also include the lack of F2A for treating women's diseases, drugs for correcting coagulation disorders after liver transplants, vascular prostheses, primary cancer treatment drugs, cefazolin-antibiotic, pantoprazole-gastrointestinal disease medication, and injectable acetaminophen in various cities, including Tehran. While the public sector relies on statistics, the production sector continuously warns about the production situation. In July 2023, Mohammad Abdehzadeh, chairman of the board of the Human Medicines Industry Syndicate, spoke about the problems in the production sector: "The Central Bank has made it harder to receive facilities, and now we have neither the ability to collect receivables nor facilities. Under these circumstances, registering orders and obtaining currency for importing raw materials becomes very difficult." According to him, nearly $600 million of the allocated currency for the pharmaceutical sector was canceled last year due to a lack of liquidity. Pharmaceutical companies are facing liquidity crises, and insurance companies are not fulfilling their commitments. In such a situation, even if there is production capacity in the country, it seems that due to a lack of liquidity or its absence, this cannot be realized, and patients become victims. Apart from these problems, on August 1, Abdehzadeh informed the first vice president in a letter that due to the failure to determine the tariff code for 700 drug lists in the country, pharmaceutical companies are unable to clear raw materials stuck in customs. The production of 99% of the country's drugs may be achieved with imported raw materials, but now they are stuck in customs, and producers warn that a drug crisis will soon be witnessed in the country. Currently, only certain pharmacies have medications like insulin, and according to one member of parliament, its distribution in small cities is very limited. A woman named Elnaz, a pseudonym for a pharmacist, tells Radio Farda about the state of domestic production: "I do not know the exact amount of domestic production, but the raw materials for these productions are imported, and as far as I know, companies are struggling to secure liquidity, which disrupts production and consequently distribution." Citizens are wandering in front of a pharmacy in Tehran to secure medication. A wave of drug crisis is on the way. Government statistics show that the percentage of domestic drug production in Iran increases every year. For example, in 2021, Iran was able to produce 97% of the country's drugs, and now this number has reached 99%. However, those who need to go from pharmacy to pharmacy with prescriptions do not accept this production capacity. Mr. Mansour, whose wife has colon cancer, has auctioned off all his possessions to try to save her. Familiar pharmacies have already made it clear that he should not hope for pharmacies. He has found a few drug dealers who offer different prices for similar medications each time. He tells Radio Farda: "I bought one medication within a month for five, 15, and 27 million tomans. Sometimes I even have to visit several pharmacies for a single serum." A report from the Health Commission of the Parliament discusses the "acute shortage" of drugs and the lack of liquidity allocated by the government. Vahid Mahallati, vice chairman of the board of the Association of Drug Distribution and Supplements, predicts that a drug crisis will emerge in the second half of 2023. He said: "It was supposed to allocate $4 billion to drugs and equipment. If we accept the government's claim of allocating $700 million in currency over three months as correct, and if this trend continues for other seasons (meaning we multiply it by four), we will not reach the number of $4 billion in the end." He also stated regarding the monetary aspect: "According to this year's resolution, in the Darouyar plan, 40 trillion tomans should be allocated to drugs. However, while it was supposed that 20 trillion tomans should have been allocated by now, only 12 trillion tomans have been allocated for drugs and equipment, with the share of drugs being 7 trillion tomans. Of course, if we accept that this allocated number has not been achieved. All of this indicates a severe liquidity shortage in the drug market." According to him, the liquidity situation is such that the negative effects of drug shortages will be tangible in the second half of the year. Dr. Parsa, a pseudonym for a pharmacist, tells Radio Farda: "The drug situation is like before, meaning that in each period, part of the drugs experiences shortages, and their deficit becomes evident. This is a continuous trend." According to the law, domestically produced drugs are not allowed to be imported. However, one of the complaints is the low effectiveness of domestic productions. Dr. Parsa states: "In some medications, foreign drugs have better effectiveness and quality. For example, using a foreign drug shows improvement and healing in the patient within a week to ten days, while its domestic equivalent must be consumed for at least a month. However, there are also drugs that both doctors and patients are more satisfied with their Iranian production than with the foreign equivalent." Pharmacies with home refrigerators. Despite Mr. Mahallati's announcement that a drug crisis should be anticipated in the second half of the year, the current situation is not calm, and to find many medications, one must resort to dealers. It is no longer necessary to go to Nasir Khusrow; various types of drugs can now be found on social media. Medications from different countries are available at different prices. Sellers all emphasize that they are from a company and labeled, meaning they are not smuggled and have been imported through a company. Various drugs from Farmaton, insulin, Gardasil to Viagra, Ritalin, and psychiatric medications or custom medications and sugar, and basically any medication you want. Citizens are wandering in front of a pharmacy in Tehran to secure medication. Mr. Behzad has nine American Gardasil injections, each selling for three million and six hundred thousand tomans. He sends a photo of the injections that are in his home refrigerator. Behzad says: "The injections were given to me by someone as a debt repayment." If you are a customer, the only way to receive it is for it to be delivered to your address. Mr. Pejman also keeps Gardasil injections in his home refrigerator. He claims that the Gardasil injections were imported by a company from Spain. He sells each for seven million and three hundred thousand tomans. He tells Radio Farda: "The same injection is sold for 13 million tomans at the clinic." He claims he received the injections from the company out of friendship. He also has the Turkish brand of the same injection. Pejman also sends the medication via delivery, and you will have no trace of the company or seller. Of course, if you hesitate for an hour in finalizing the order, he deletes all chats and negotiations and no longer responds. All online sellers do this to leave no trace. Ms. Faiza has been on the waiting list at the pharmacy for several months to get Gardasil. She tells Radio Farda: "Although they say pharmacies have a specific quota, several pharmacies have said that only if I pay the full cost, I can receive it after a few weeks. The price of each is also different." Ms. Tuba tells Radio Farda: "Only foreign sugar pills can keep her sugar balanced, and the Iranian version does not work." Another seller on Telegram, who introduces himself as Nima, imports drugs in limited quantities and, as he says, "lightly." He has suitcase imports with travelers from Turkey. His specialty is rare and hard-to-find medications. You just need to give the name of the drug. In summary, all drugs that cannot be found in pharmacies are available here. Dr. Parsa considers this method of selling to be common and says these are known as "market drugs." These dealers have various medications. The Nasir Khusrow market is online. According to him, the pulse of the market is in the hands of dealers, and they are aware of the market shortages; accordingly, they supply the shortages at high prices. Of course, selling drugs has a high-profit margin, and they sell shortages at least at double the price. Ms. Golfer, a pseudonym for a pharmacy technician in Tehran, tells Radio Farda: "The shortage of drugs known as rare is completely evident." Citizens are wandering in front of a pharmacy in Tehran to secure medication. She is aware of the online drug sales markets and says: "Sellers import drugs in various ways, from suitcase methods and travelers to smuggling by couriers or even officially through companies. For example, it is smuggled in bulk from Turkey to Iran." She discusses the fluctuations in the drug market: "Some brands of drugs with good effectiveness are no longer allowed to be imported. An example is the Triamhexal injection produced in Germany. Given the need and increased market demand, dealers start importing and also set higher prices. In some cases, a pharmacy that previously had the drug prefers to sell it at a higher price in the free market to earn more profit." This is how easily the dealer market is thriving day by day, especially as the drug situation continues to worsen and dark days for patients are on the way. According to the Iranian Pharmaceutical Association, only drugs that are not produced domestically are allowed to be imported. This means that the doctor must emphasize the foreign version and not confirm the effectiveness of the domestic equivalent. However, in a situation where this procedure exists and the equivalent cannot be found, there is no choice but to buy from drug dealers. Those who have no name, no photo, do not register their number on Telegram. More importantly, they do not allow buyers to approach them. According to Ms. Golfer, the drug market experiences shortages periodically. In this context, the drugs for special and cancer patients are more evident. This is a continuous cycle; only the type of shortages changes in each period.
The Black Market for Medicine in Iran; From Nasir Khusrow to Telegram
Iran's pharmaceutical market is facing severe shortages and a burgeoning black market for medications, despite government claims of 99% domestic production. Citizens are struggling to find essential drugs, leading to reliance on dealers and online platforms for access. This situation highlights the disconnect between official statistics and the reality of healthcare access in Iran.
👥 Key Players
📰 What Happened
Iran is experiencing severe drug shortages, leading to a black market for medications despite government claims of high domestic production. Citizens are struggling to find essential drugs, resulting in reliance on dealers and online platforms.
- 99% of Iran's medicines are claimed to be domestically produced, yet shortages persist.
- Pharmaceutical companies face liquidity crises, impacting their ability to produce and distribute drugs.
💡 Why It Matters
📚 Background
Iran's healthcare system has been under strain due to economic sanctions and mismanagement, leading to recurring drug shortages. The reliance on a black market for essential medications reflects deeper systemic issues.
Translated from the original and edited for English readers. View original source →
Translation confidence: 85%